Bruker Advances Functional Proteomics With Novel Timsultra Aip And Timsomni Workflows For Drug Discovery & Development And Disease Biology Research
Bruker Corporation NASDAQ:BRKR
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bruker unveils timsUltra AIP and timsOmni proteomics workflows
Bruker announced new timsUltra AIP and timsOmni workflows for protein-sequence coverage, targeted validation, glycopeptide characterization and structural proteomics. The company also said Spectronaut v21 transfer learning can adapt to new mass spectrometry capabilities.